XML 36 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating expenses:    
Research and development $ 2,964 $ 2,764
General and administrative 1,284 860
Total operating expenses 4,248 3,624
Loss from operations (4,248) (3,624)
Other income:    
Interest income 16 35
Total other income 16 35
Net loss (4,232) (3,589)
Comprehensive loss $ (4,232) $ (3,589)
Net loss per share attributable to common stockholders—basic and diluted $ (18.70) $ (21.54)
Weighted-average common shares outstanding—basic and diluted 230,860 170,156